Proopiomelanocortin (POMC) and Psychodermatology

Overview

Journal Skin Health Dis

Publisher Oxford University Press

Specialty Dermatology

Date 2023 Jun 5

PMID 37275429

Authors

George W M Millington

Hannah E Palmer

Affiliations

Soon will be listed here.

Abstract

Psychodermatology is the crossover discipline between Dermatology and Clinical Psychology and/or Psychiatry. It encompasses both Psychiatric diseases that present with cutaneous manifestations (such as delusional infestation) or more commonly, the psychiatric or psychological problems associated with skin disease, such as depression associated with psoriasis. These problems may be the result either of imbalance in or be the consequence of alteration in the homoeostatic endocrine mechanisms found in the systemic hypothalamic-pituitary-adrenal axis or in the local cutaneous corticotrophin-releasing factor-proopiomelanocortin-corticosteroid axis. Alteration in either of these systems can lead to immune disruption and worsening of immune dermatoses and vice-versa. These include diseases such as psoriasis, atopic eczema, acne, alopecia areata, vitiligo and melasma, all of which are known to be linked to stress. Similarly, stress and illnesses such as depression are linked with many immunodermatoses and may reflect alterations in the body's central and peripheral neuroendocrine stress pathways. It is important to consider issues pertaining to skin of colour, particularly with pigmentary disorders.

Citing Articles

Exploring the Relationship Between Psychiatric Illness and Dermatological Disorders: A Narrative Review.

Kaye A, Islam R, Castine A, Wester G, Barham W, Nguyen C Cureus. 2025; 17(2):e78731.

PMID: 40065888 PMC: 11892542. DOI: 10.7759/cureus.78731.

Deep Learning-Based Drug Compounds Discovery for Gynecomastia.

Lu Y, Kim B, Zeng J, Chen Z, Zhu M, Tang Y Biomedicines. 2025; 13(2).

PMID: 40002676 PMC: 11852009. DOI: 10.3390/biomedicines13020262.

Prevention of Melasma During Pregnancy: Risk Factors and Photoprotection-Focused Strategies.

Zhao L, Fu X, Cheng H Clin Cosmet Investig Dermatol. 2024; 17:2301-2310.

PMID: 39430643 PMC: 11490249. DOI: 10.2147/CCID.S488663.

The Hormonal Background of Hair Loss in Non-Scarring Alopecias.

Owecka B, Tomaszewska A, Dobrzeniecki K, Owecki M Biomedicines. 2024; 12(3).

PMID: 38540126 PMC: 10968111. DOI: 10.3390/biomedicines12030513.

Proopiomelanocortin (POMC) and psychodermatology.

Millington G, Palmer H Skin Health Dis. 2023; 3(3):e201.

PMID: 37275429 PMC: 10233089. DOI: 10.1002/ski2.201.

References

Bergler-Czop B, Miziolek B, Brzezinska-Wcislo L . Alopecia areata - hyperactivity of the hypothalamic-pituitary-adrenal axis is a myth?. J Eur Acad Dermatol Venereol. 2017; 31(9):1555-1561. DOI: 10.1111/jdv.14346. View

Lee N, Kim B, Lee C, Lee Y, Lee S, Hwang H . Role of 11β-hydroxysteroid dehydrogenase type 1 in the development of atopic dermatitis. Sci Rep. 2020; 10(1):20237. PMC: 7678864. DOI: 10.1038/s41598-020-77281-x. View

Qu N, He Y, Wang C, Xu P, Yang Y, Cai X . A POMC-originated circuit regulates stress-induced hypophagia, depression, and anhedonia. Mol Psychiatry. 2019; 25(5):1006-1021. PMC: 7056580. DOI: 10.1038/s41380-019-0506-1. View

Millington G, Tung Y, Hewson A, ORahilly S, Dickson S . Differential effects of alpha-, beta- and gamma(2)-melanocyte-stimulating hormones on hypothalamic neuronal activation and feeding in the fasted rat. Neuroscience. 2001; 108(3):437-45. DOI: 10.1016/s0306-4522(01)00428-6. View

Fischer T, Bergmann A, Kruse N, Kleszczynski K, Skobowiat C, Slominski A . New effects of caffeine on corticotropin-releasing hormone (CRH)-induced stress along the intrafollicular classical hypothalamic-pituitary-adrenal (HPA) axis (CRH-R1/2, IP -R, ACTH, MC-R2) and the neurogenic non-HPA axis (substance P, p75 and TrkA).... Br J Dermatol. 2020; 184(1):96-110. PMC: 7962141. DOI: 10.1111/bjd.19115. View

Andoh T, Akasaka C, Shimizu K, Lee J, Yoshihisa Y, Shimizu T . Involvement of α-Melanocyte-Stimulating Hormone-Thromboxane A System on Itching in Atopic Dermatitis. Am J Pathol. 2019; 189(9):1775-1785. DOI: 10.1016/j.ajpath.2019.05.017. View

Stanganelli I, Gandini S, Magi S, Mazzoni L, Medri M, Agnoletti V . Sunbed use among subjects at high risk of melanoma: an Italian survey after the ban. Br J Dermatol. 2013; 169(2):351-7. DOI: 10.1111/bjd.12384. View

Peters E . Stressed skin?--a molecular psychosomatic update on stress-causes and effects in dermatologic diseases. J Dtsch Dermatol Ges. 2016; 14(3):233-52. DOI: 10.1111/ddg.12957. View

Anglin R, Rosebush P, Mazurek M . The neuropsychiatric profile of Addison's disease: revisiting a forgotten phenomenon. J Neuropsychiatry Clin Neurosci. 2006; 18(4):450-9. DOI: 10.1176/jnp.2006.18.4.450. View

10.

Millington G, Collins A, Lovell C, Leslie T, Yong A, Morgan J . British Association of Dermatologists' guidelines for the investigation and management of generalized pruritus in adults without an underlying dermatosis, 2018. Br J Dermatol. 2018; 178(1):34-60. DOI: 10.1111/bjd.16117. View

11.

Kaur M, Liguori A, Fleischer Jr A, Feldman S . Plasma beta-endorphin levels in frequent and infrequent tanners before and after ultraviolet and non-ultraviolet stimuli. J Am Acad Dermatol. 2006; 54(5):919-20. DOI: 10.1016/j.jaad.2006.01.062. View

12.

Lee S, Pi L, Park Y, Whang K, Jeon S, Lee W . The effect of proopiomelanocortin-derived peptides on the immune system of human hair follicles. J Dermatol Sci. 2009; 55(3):195-7. DOI: 10.1016/j.jdermsci.2009.06.006. View

13.

Buske-Kirschbaum A, Trikojat K, Tesch F, Schmitt J, Roessner V, Luksch H . Altered hypothalamus-pituitary-adrenal axis function: A relevant factor in the comorbidity of atopic eczema and attention deficit/hyperactivity disorder?. Psychoneuroendocrinology. 2018; 105:178-186. DOI: 10.1016/j.psyneuen.2018.12.005. View

14.

Lam B, Cimino I, Polex-Wolf J, Nicole Kohnke S, Rimmington D, Iyemere V . Heterogeneity of hypothalamic pro-opiomelanocortin-expressing neurons revealed by single-cell RNA sequencing. Mol Metab. 2017; 6(5):383-392. PMC: 5404100. DOI: 10.1016/j.molmet.2017.02.007. View

15.

Kaur M, Liguori A, Lang W, Rapp S, Fleischer Jr A, Feldman S . Induction of withdrawal-like symptoms in a small randomized, controlled trial of opioid blockade in frequent tanners. J Am Acad Dermatol. 2006; 54(4):709-11. DOI: 10.1016/j.jaad.2005.11.1059. View

16.

Swope V, Abdel-Malek Z . MC1R: Front and Center in the Bright Side of Dark Eumelanin and DNA Repair. Int J Mol Sci. 2018; 19(9). PMC: 6163888. DOI: 10.3390/ijms19092667. View

17.

Lee E, Nam Y, Kang S, Choi E, Han I, Kim J . The local hypothalamic-pituitary-adrenal axis in cultured human dermal papilla cells. BMC Mol Cell Biol. 2020; 21(1):42. PMC: 7310274. DOI: 10.1186/s12860-020-00287-w. View

18.

Deshpande S, Khatu S, Pardeshi G, Gokhale N . Cross-sectional study of psychiatric morbidity in patients with melasma. Indian J Psychiatry. 2018; 60(3):324-328. PMC: 6201670. DOI: 10.4103/psychiatry.IndianJPsychiatry_115_16. View

19.

Fortin S, Chen J, Grill H, Hayes M . The Mesencephalic Trigeminal Nucleus Controls Food Intake and Body Weight via Hindbrain POMC Projections. Nutrients. 2021; 13(5). PMC: 8152732. DOI: 10.3390/nu13051642. View

20.

Acevedo-Rodriguez A, Kauffman A, Cherrington B, Borges C, Roepke T, Laconi M . Emerging insights into hypothalamic-pituitary-gonadal axis regulation and interaction with stress signalling. J Neuroendocrinol. 2018; 30(10):e12590. PMC: 6129417. DOI: 10.1111/jne.12590. View